(S,R,S)-AHPC-PEG2-C4-Cl


CAS No. : 1835705-57-1

(Synonyms: VH032-PEG2-C4-Cl; VHL Ligand-Linker Conjugates 7; E3 ligase Ligand-Linker Conjugates 10)

1835705-57-1
Price and Availability of CAS No. : 1835705-57-1
Size Price Stock
50mg $344 In-stock
100mg $550 In-stock
500mg $1950 In-stock
1g $3350 In-stock
2g $4900 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-103607
M.Wt: 651.26
Formula: C32H47ClN4O6S
Purity: >98 %
Solubility: DMSO : ≥ 50 mg/mL;Ethanol : 50 mg/mL (ultrasonic);H2O : 50 mg/mL (ultrasonic)
Introduction of 1835705-57-1 :

(S,R,S)-AHPC-PEG2-C4-Cl (VH032-PEG2-C4-Cl) is a conjugate of ligands for E3 and 13-atom-length linker. The connector of linker is Halogen group. (S,R,S)-AHPC-PEG2-C4-Cl incorporates the (S,R,S)-AHPC based VHL ligand and an alkyl/ether-based linker. (S,R,S)-AHPC-PEG2-C4-Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1]. IC50 & Target:E3 Ligase Ligand-Linker Conjugate[1] In Vitro: (S,R,S)-AHPC-PEG2-C4-Cl uses the VHL ligand[1]. The linkers contain a mixture of hydrophobic and hydrophilic moieties to balance the hydrophobicity/hydrophilicity of the resulting hybrid compounds. PROTACs that induce the degradation of an oncogenic tyrosine kinase, BCR-ABL has been developed. (S,R,S)-AHPC-PEG2-C4-Cl can be attached to potent TKIs (bosutinib and dasatinib) that mediate the degradation of c-ABL and BCR-ABL by hijacking either CRBN or VHL E3 ubiquitin ligase[2].

Your information is safe with us.